Description
Food supplement based on alpha-lipoic acid, Boswellia serrata, methylsulfonylmethane, and bromelain.
A nutraceutical developed with an innovative ACTISYSTEMBXES "controlled-release" technology that allows for the production of preparations with gradual and diversified absorption: the active ingredients are released only in sites characterized by an acute inflammatory state. This technology makes it possible to lower the minimum effective doses to 1/10 of the dose normally used in treatment.

Ingredients
Alpha-lipoic acid, methylsulfonylmethane (MSM), food-grade gelatin, boswellia (Boswellia serrata Roxb. ex Colebr.) resin dry extract titrated to 65% boswellic acids, bromelain 2,500 GDU/g, sodium alginate, D-mannose; anti-caking agent: magnesium salts of fatty acids; anhydrous dibasic sodium phosphate; bulking agent: microcrystalline cellulose; dibasic calcium phosphate, magnesium glycerophosphate, magnesium chloride hexahydrate.

Gluten-free.
Lactose-free.

Nutritional characteristics

Average values	per 1 capsule
Alpha-lipoic acid	240 mg
MSM	200 mg
Boswellia dry extract boswellic acid content	40 mg 26 mg
Bromelain 2,500 GDU	20 mg (equal to 50 GDU)

Directions for use
It is recommended to take 1 capsule in the morning on an empty stomach.

Warnings
Supplements are not intended as substitutes for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended dose. Keep out of reach of children under 3 years of age.
For product use, it is advisable to consult a doctor. In rare cases, lipoic acid may cause hypoglycemia.

Storage
Store in a cool, dry place.
Shelf life unopened: 24 months.

Format
Pack of 20 sustained-release capsules
Net weight 14 g.